Screening genes to predict who will respond badly to drugs
Research mapping genetic markers is being used to save lives at risk from a range of medical treatments, tests and vaccines.
Apr 28, 2021
0
0
Research mapping genetic markers is being used to save lives at risk from a range of medical treatments, tests and vaccines.
Apr 28, 2021
0
0
Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have discovered distinct blood signatures present in patients with COVID-19 that could significantly improve COVID-19 testing and long-term ...
Jan 12, 2021
0
18
Murdoch researchers are redesigning health care for Aboriginal people. The results may radically improve life outcomes for many.
Nov 10, 2020
0
1
Murdoch University's Australian National Phenome Center (ANPC) working with researchers at the University of Cambridge have developed a predictive metabolic model for COVID-19 infection that shows multi-organ effects.
Aug 21, 2020
2
561
Students and researchers from Murdoch are investigating ways improve the telehealth services and programs delivered to the multiple sclerosis community to increase participation rates.
Aug 14, 2020
0
0
Murdoch University researchers have identified a new technique to potentially link serial killer victims based on subtle similarities in their faces.
Jul 30, 2020
0
3
Murdoch University's Australian National Phenome Center (ANPC) working with scientists at Imperial College London have developed a new integrative strategy for identifying biomarkers of health and disease.
Jul 20, 2020
0
124
Researchers at the Australian National Phenome Centre at Murdoch University and partners at Imperial College London have made a major breakthrough in understanding how individuals can have different reactions to the same ...
Jun 18, 2020
1
79
New research out of Murdoch University has shown that saffron can enhance the quality of sleep in adults who have been experiencing poor sleep.
Feb 28, 2020
0
28
Research led by Professor Steve Wilton and Professor Sue Fletcher and licensed to Sarepta Therapeutics has delivered a second treatment for Duchenne muscular dystrophy, with the drug gaining accelerated approval by the U.S. ...
Jan 8, 2020
0
14167